Trospium Chloride Capsule, Extended Release
Product Images NDC 71335-2931

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Trospium Chloride (NDC 71335-2931). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Image 01)

FDA Label Image

Figure 1 (Image 02)

Figure 1 (Image 02)
This is a data table showing the plasma concentration (ng/mL) of Trospium Chloride Extended-Release Capsules 60mg at different time points (2, 16, 22 hours post-dose). It presents information on the drug's concentration in the bloodstream over time.*
FDA Label Image

Figure 2 (Image 03)

FDA Label Image

Figure 3 (Image 04)

FDA Label Image

Figure 4 (Image 05)

FDA Label Image

Figure 5 (Image 06)

FDA Label Image

Label (Lbl713352931)

Label (Lbl713352931)
This is a package insert for Trospium Chloride extended-release capsules containing 60 mg each. The medication should be kept in a secure container and stored at a temperature between 20° to 25°C. The usual dosage is once daily. The insert suggests scanning the QR Code for full prescribing information and mentions that the capsules are to be dispensed in a child-resistant container with a patient information leaflet. The capsules are manufactured by Bryant Ranch Prepack, Inc. and Sidmak Laboratories Pvt. Ltd.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.